Healthcare >> CEO Interviews >> July 31, 2012
David C. Goldberg, Vice President, Corporate Development and Interim President of Enzo Clinical Labs, has been employed with the company since 1985. He has held several managerial positions within Enzo Biochem, Inc. Mr. Goldberg also held management and marketing positions with DuPont NEN and Gallard Schlesinger Industries, Inc., before joining the company. He received an M.S. in microbiology from Rutgers, The State University of New Jersey, and an MBA in finance from New York University. Profile
Barry W. Weiner, President, Chief Financial Officer and Director, is a founder of Enzo Biochem, Inc. He has served as the company's President since 1996, and previously held the position of Executive Vice President. Before his employment with Enzo Biochem, Inc., he worked in several managerial and marketing positions at Colgate-Palmolive. Mr. Weiner is formerly a Director of the New York Biotechnology Association. He received his Bachelor of Arts in economics from New York University and a Master of Business Administration in finance from Boston University. Profile
Mr. Weiner: Enzo is focused in the area of gene labeling, gene
